Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients
dc.contributor.author | Burkill, S | en_US |
dc.contributor.author | Porsbjerg, CM | en_US |
dc.contributor.author | Bourdin, A | en_US |
dc.contributor.author | Tran, TN | en_US |
dc.contributor.author | Martin, N | en_US |
dc.contributor.author | Katial, R | en_US |
dc.contributor.author | Barker, P | en_US |
dc.contributor.author | Wechsler, ME | en_US |
dc.contributor.author | Maspero, J | en_US |
dc.contributor.author | Bosnic-Anticevich, S | en_US |
dc.contributor.author | Chung, LP | en_US |
dc.contributor.author | Katsoulotos, G | en_US |
dc.contributor.author | Christoff, GC | en_US |
dc.contributor.author | Popov, TA | en_US |
dc.contributor.author | Sadatsafavi, M | en_US |
dc.contributor.author | Torres-Duque, CA | en_US |
dc.contributor.author | Ulrik, C | en_US |
dc.contributor.author | Assing, KD | en_US |
dc.contributor.author | Hansen, S | en_US |
dc.contributor.author | Altraja, A | en_US |
dc.contributor.author | Lehtimaki, LA | en_US |
dc.contributor.author | Papadopoulos, NG | en_US |
dc.contributor.author | Kostikas, K | en_US |
dc.contributor.author | Salvi, S | en_US |
dc.contributor.author | Costello, RW | en_US |
dc.contributor.author | Francesca, P | en_US |
dc.contributor.author | Iwanaga, T | en_US |
dc.contributor.author | Rhee, CK | en_US |
dc.contributor.author | Al-Ahmad, M | en_US |
dc.contributor.author | Larenas-Linnemann, D | en_US |
dc.contributor.author | Fonseca, JA | en_US |
dc.contributor.author | Amaral, R | en_US |
dc.contributor.author | Alving, K | en_US |
dc.contributor.author | Al-Lehebi, R | en_US |
dc.contributor.author | De-Llano, LP | en_US |
dc.contributor.author | Kirenga, B | en_US |
dc.contributor.author | Tsai, M | en_US |
dc.contributor.author | Mahboub, B | en_US |
dc.contributor.author | Pfeffer, PE | en_US |
dc.contributor.author | Henley, W | en_US |
dc.contributor.author | Liu, Y | en_US |
dc.contributor.author | Lyu, J | en_US |
dc.contributor.author | Goh, C | en_US |
dc.contributor.author | Uthaman, T | en_US |
dc.contributor.author | Price, D | en_US |
dc.contributor.author | Townend, J | en_US |
dc.date.accessioned | 2023-03-07T15:06:31Z | |
dc.date.issued | 2022 | en_US |
dc.identifier.issn | 0903-1936 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/84829 | |
dc.subject | Severe asthma | en_US |
dc.subject | Biomarkers | en_US |
dc.subject | Treatments | en_US |
dc.title | Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients | en_US |
dc.type | Conference Proceeding | |
dc.identifier.doi | 10.1183/13993003.congress-2022.3305 | en_US |
pubs.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000893392404430&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 60 | en_US |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |